The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care—COLCHICOVID study

BACKGROUND: There is no strong evidence that any drug is beneficial either for the treatment of SARS-CoV-2 disease or for post-exposure prophylaxis. Therefore, clinical research is crucial to generate results and evaluate strategies against COVID-19. Primary care (PC) centers, the first level of car...

Descripción completa

Detalles Bibliográficos
Autores principales: Estebanez, Elena Bustamante, Alconero, Lucía Lavín, Fernández, Beatriz Josa, Marguello, Monica Gozalo, Caro, Juan Carlos López, Vallejo, Jonathan Diez, Sampedro, Marta Fernandez, Cacho, Pedro Muñoz, Espiga, Carlos Richard, Saiz, María Mar García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419390/
https://www.ncbi.nlm.nih.gov/pubmed/34488841
http://dx.doi.org/10.1186/s13063-021-05544-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419390/
https://www.ncbi.nlm.nih.gov/pubmed/34488841
http://dx.doi.org/10.1186/s13063-021-05544-7

Ejemplares similares